Residual Risk in Heart Failure and the Need for Simultaneous Implementation and Innovation
Related Posts
Waqas SA, Sohail MU, Saad M, Minhas AMK, Greene SJ, Fudim M, Fonarow GC, Abramov D, Khan MS, Ahmed R. Efficacy of GLP-1 Receptor Agonists[...]
Liu O, Soo S, Bloom M, Alvarez-Cardona J, Katz JN, Cheng RK, Yang EH, Leiva O. Outcomes of Patients with Cancer Admitted with Heart Failure-Associated[...]
Marcus GM, Tung R, Gerstenfeld EP, Hue TF, Lin F, Cheng J, Weiss JP, Tzou WS, Hsia H, Ehdaie A, Cooper DH, Bunch TJ, Arkles[...]